Table of Contents Table of Contents
Previous Page  84 / 86 Next Page
Information
Show Menu
Previous Page 84 / 86 Next Page
Page Background

82

NCCN Guidelines for Patients

®

Peripheral T-cell Lymphoma, Version 1.2016

Index

biopsy

10, 15, 18–19, 22, 41, 49, 53, 57

blood tests

16, 22

chemotherapy

16, 26–29, 32–33, 36, 40–41, 43, 48–49,

51–53, 55–57, 59

clinical trial

25, 34, 36, 40–59

complementary and alternative medicine

34

complete blood count

15–16

comprehensive metabolic panel

15–16

computed tomography

17, 18, 30, 41, 49

diagnosis

4, 10–11, 39, 64, 68

fertility

15, 21

immunohistochemistry

10–11

immunomodulators

27–28

involved-site radiation therapy

30, 36, 40–41, 44–45,

48–49, 52–53, 56–57, 60

lymphatic system

6–8, 12, 19

lymphocyte

7, 8, 12

medical history

14–15

NCCN Member Institutions

80

NCCN panel members

79

observation

40–41, 48–49, 52–53, 56–57

pathology report

10, 64, 68

physical exam

15

positron emission tomography/computed tomography

15, 17–18, 22, 30, 41

radiation therapy

30, 40–59

stem cell transplant

26, 32–33, 36, 40–59

steroids

28, 36

supportive care

31, 39–59

targeted therapy

27–29

Index